Abstract
AimsAlthough current guidelines recommend reduction of salt intake in patients with diabetes, the benefits of reducing salt intake in people with type 2 diabetes mellitus (T2DM) lack clear evidence. Therefore, we performed a meta-analysis of available randomized controlled trials (RCTs) of sodium restriction and blood pressure (BP) in patients with T2DM. Data synthesisWe performed a systematic search of the online databases that evaluated the effect of dietary sodium restriction on BP in patients with T2DM. Sodium intake was expressed by 24 h urinary sodium excretion (UNaV). Q statistics and I2 were used to explore between-study heterogeneity. A random-effects model was used in the presence of significant heterogeneity; otherwise, a fixed-effects model was applied. Eight RCTs with 10 trials (7 cross-over and 3 parallel designs) were included in the meta-analysis. Compared with ordinary sodium intake, dietary sodium restriction significantly decreased UNaV (weighted mean difference, WMD: −38.430 mmol/24 h; 95% CI: −41.665 mmol/24 h to −35.194 mmol/24 h). Sodium restriction significantly lowered systolic BP (WMD: −5.574 mm Hg; 95% CI: −8.314 to −2.834 mm Hg; I2 = 0.0%) and diastolic BP (WMD: −1.675 mm Hg; 95% CI: −3.199 to −0.150 mm Hg; I2 = 0.0%) with low heterogeneity among the studies. No publication bias was found from Begg's and Egger's tests. ConclusionsSodium restriction significantly reduces SBP and DBP in patients with T2DM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have